Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
Website: rapidmicrobio.com



Growth: Good revenue growth rate 20.0%, there is acceleration compared to average historical growth rates 2.5%. The revenue growth dynamics is unstable

Profitability: LTM EBITDA margin is negative, -230.4%. On average the margin is decreasing steadily. Gross margin is low, -27.1%. In the last quarter the company beat the estimated EPS. The company was ahead of estimated EPS in 40% of quarters (showing a gain of $0.00 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -52.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 20.3% higher than minimum and 96.4% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued -9.3x by EV / Sales multiple

Key Financials (Download financials)

Ticker: RPID
Share price, USD:  (0.0%)0.89
year average price 0.9901  


year start price 0.8300 2023-05-08

max close price 1.1800 2023-09-15

min close price 0.7400 2023-12-29

current price 0.8900 2024-05-06
Common stocks: 43 245 835

Dividend Yield:  0.0%
Last revenue growth (y/y):  20.0%
Last growth of EBITDA (y/y):  ---
Historical revenue growth:  2.5%
Historical growth of EBITDA:  0.0%
EV / Sales: -1.5x
Margin (EBITDA LTM / Revenue): -230.4%
Fundamental value created in LTM:
Market Cap ($m): 38
Net Debt ($m): -72
EV (Enterprise Value): -34
Price to Book: 0.4x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-05-03Zacks Investment Research

Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates

2024-03-01Seeking Alpha

Rapid Micro Biosystems, Inc. (RPID) Q4 2023 Earnings Call Transcript

2024-02-20GlobeNewsWire

Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024

2024-01-03GlobeNewsWire

Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference

2023-11-07GlobeNewsWire

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

2023-11-03Zacks Investment Research

Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Tops Revenue Estimates

2023-10-19GlobeNewsWire

Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023

2023-09-06GlobeNewsWire

Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference

2023-08-04Seeking Alpha

Rapid Micro Biosystems, Inc. (RPID) Q2 2023 Earnings Call Transcript

2023-08-04Zacks Investment Research

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol RPID RPID RPID RPID RPID RPID RPID
reportedCurrency USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-05-03 2024-03-01 2023-11-03 2023-08-04 2023-05-09 2023-03-10 2022-11-10
acceptedDate 2024-05-03 16:11:31 2024-03-01 16:38:47 2023-11-03 16:16:08 2023-08-04 16:32:22 2023-05-09 17:28:21 2023-03-10 17:30:56 2022-11-10 16:44:39
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 6M 6M 6M 5M 5M 4M 5M
costOfRevenue 7M 7M 8M 7M 7M 7M 8M
grossProfit -2M -172 000 -2M -2M -2M -3M -3M
grossProfitRatio -0.271 -0.027 -0.265 -0.378 -0.356 -0.595 -0.590
researchAndDevelopmentExpenses 4M 3M 3M 3M 3M 3M 3M
generalAndAdministrativeExpenses 6M 6M 6M 7M 6M 7M 7M
sellingAndMarketingExpenses 3M 3M 3M 3M 3M 4M 4M
sellingGeneralAndAdministrativeExpenses 9M 9M 10M 10M 10M 11M 11M
otherExpenses 2M -17 000 -26 000 -29 000 -11 000 -11 000 0
operatingExpenses 13M 12M 13M 13M 13M 15M 14M
costAndExpenses 20M 19M 21M 20M 20M 22M 22M
interestIncome 0 1M 1M 1M 1M 0 0
interestExpense 0 992 000 0 0 -992 000 831 000 575 000
depreciationAndAmortization 1M 794 000 781 000 771 000 759 000 860 000 734 000
ebitda -13M -11M -14M -14M -15M -17M -16M
ebitdaratio -2.346 -1.798 -2.224 -2.855 -2.954 -3.946 -3.408
operatingIncome -14M -12M -14M -15M -15M -17M -17M
operatingIncomeRatio -2.544 -1.923 -2.351 -3.010 -2.954 -3.946 -3.563
totalOtherIncomeExpensesNet 954 000 1M -26 000 -29 000 992 000 820 000 554 000
incomeBeforeTax -13M -11M -13M -14M -14M -16M -16M
incomeBeforeTaxRatio -2.374 -1.762 -2.178 -2.801 -2.757 -3.759 -3.446
incomeTaxExpense 3000.000 8000.000 10000.000 6000.000 7000.000 7000.000 7000.000
netIncome -13M -11M -13M -14M -14M -16M -16M
netIncomeRatio -2.374 -1.763 -2.179 -2.802 -2.758 -3.760 -3.448
eps -0.310 -0.260 -0.310 -0.330 -0.320 -0.390 -0.380
epsdiluted -0.310 -0.260 -0.310 -0.330 -0.320 -0.390 -0.380
weightedAverageShsOut 43M 43M 43M 43M 43M 43M 43M
weightedAverageShsOutDil 43M 43M 43M 43M 43M 43M 43M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol RPID RPID RPID RPID RPID RPID RPID
reportedCurrency USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-05-03 2024-03-01 2023-11-03 2023-08-04 2023-05-09 2023-03-10 2022-11-10
acceptedDate 2024-05-03 16:11:31 2024-03-01 16:38:47 2023-11-03 16:16:08 2023-08-04 16:32:22 2023-05-09 17:28:21 2023-03-10 17:30:56 2022-11-10 16:44:39
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 22M 24M 24M 29M 24M 27M 26M
shortTermInvestments 57M 68M 66M 77M 75M 82M 89M
cashAndShortTermInvestments 80M 92M 89M 106M 100M 109M 115M
netReceivables 5M 6M 4M 4M 6M 5M 5M
inventory 20M 20M 20M 21M 21M 21M 21M
otherCurrentAssets 3M 3M 802 000 891 000 3M 705 000 726 000
totalCurrentAssets 108M 120M 115M 133M 129M 139M 145M
propertyPlantEquipmentNet 19M 19M 19M 20M 20M 21M 21M
goodwill 0 0 0 0 0 0 0
intangibleAssets 0 0 800 000 900 000 0 0 0
goodwillAndIntangibleAssets 0 0 800 000 900 000 0 0 0
longTermInvestments 284 000 3M 15M 7M 22M 30M 35M
taxAssets 0 0 -800 000 -900 000 0 0 0
otherNonCurrentAssets 683 999 769 999 1M 1M 1M 1M 2M
totalNonCurrentAssets 20M 23M 35M 28M 44M 52M 57M
otherAssets 1.000 1.000 0 0 0 0 0
totalAssets 128M 143M 150M 161M 173M 191M 202M
accountPayables 1M 2M 3M 1M 1M 5M 4M
shortTermDebt 1M 1M 841 000 802 000 773 000 766 000 747 000
taxPayables 259 000 252 000 287 000 254 000 266 000 329 000 230 000
deferredRevenue 6M 6M 5M 5M 5M 5M 3M
otherCurrentLiabilities 7M 10M 7M 8M 6M 8M 7M
totalCurrentLiabilities 16M 19M 16M 14M 14M 19M 15M
longTermDebt 6M 6M 7M 7M 7M 7M 7M
deferredRevenueNonCurrent 0 0 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0
otherNonCurrentLiabilities 272 000 263 000 255 000 247 000 238 000 229 000 -133 000
totalNonCurrentLiabilities 6M 6M 7M 7M 7M 7M 8M
otherLiabilities 0 0 0 0 0 0 0
capitalLeaseObligations 6M 6M 7M 7M 8M 8M 8M
totalLiabilities 22M 25M 22M 21M 21M 26M 23M
preferredStock 0 0 0 0 0 0 0
commonStock 428 000 424 000 424 000 423 000 423 000 421 000 420 000
retainedEarnings -442M -428M -417M -404M -390M -376M -359M
accumulatedOtherComprehensiveIncomeLoss -78 000 -101 000 -453 000 -695 000 -662 000 -1M -1M
othertotalStockholdersEquity 547M 546M 545M 544M 542M 541M 539M
totalStockholdersEquity 106M 118M 128M 140M 152M 164M 179M
totalEquity 106M 118M 128M 140M 152M 164M 179M
totalLiabilitiesAndStockholdersEquity 128M 143M 150M 161M 173M 191M 202M
minorityInterest 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 128M 143M 150M 161M 173M 191M 202M
totalInvestments 57M 71M 80M 85M 98M 111M 124M
totalDebt 7M 7M 7M 7M 8M 8M 8M
netDebt -15M -17M -16M -21M -17M -19M -18M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Cash Flow Statement

Property 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol RPID RPID RPID RPID RPID RPID RPID
reportedCurrency USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M
fillingDate 2024-05-03 2024-03-01 2023-11-03 2023-08-04 2023-05-09 2023-03-10 2022-11-10
acceptedDate 2024-05-03 16:11:31 2024-03-01 16:38:47 2023-11-03 16:16:08 2023-08-04 16:32:22 2023-05-09 17:28:21 2023-03-10 17:30:56 2022-11-10 16:44:39
calendarYear 2024.000 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q1 Q4 Q3 Q2 Q1 Q4 Q3
netIncome -13M -11M -13M -14M -14M -16M -16M
depreciationAndAmortization 1M 794 000 781 000 771 000 759 000 860 000 734 000
deferredIncomeTax 0 1M -560 000 -620 000 0 0 0
stockBasedCompensation 0 1M 1M 1M 1M 1M 673 000
changeInWorkingCapital -4M 76 000 2M 3M -5M 3M -434 000
accountsReceivables 611 000 -2M -451 000 2M -142 000 -710 000 -559 000
inventory -543 000 233 000 747 000 4000.000 209 000 -371 000 199 000
accountsPayables -809 000 -1M 2M 77 000 -4M 2M 847 000
otherWorkingCapital -3M 3M -305 000 1 000 000 -481 000 2M -921 000
otherNonCashItems 4M -1M 314 000 305 000 -246 000 -3000.000 261 000
netCashProvidedByOperatingActivities -16M -9M -10M -9M -17M -12M -15M
investmentsInPropertyPlantAndEquipment -585 000 -418 000 -453 000 -215 000 -759 000 -811 000 -2M
acquisitionsNet 0 28M -5M -14M 0 0 0
purchasesOfInvestments -4M -12M -24M -9M -18M -24M -37M
salesMaturitiesOfInvestments 18M 22M 30M 23M 33M 38M 30M
otherInvestingActivites 0 -28M 5M 14M 0 0 0
netCashUsedForInvestingActivites 14M 10M 5M 13M 14M 13M -9M
debtRepayment -10000.000 -10000.000 -9000.000 -9000.000 -9000.000 -9000.000 -8000.000
commonStockIssued 168 000 -2000.000 57 000 0 7000.000 566 000 0
commonStockRepurchased 168 000 56 000 0 0 124 000 160 000 0
dividendsPaid 0 0 0 0 -7000.000 0 0
otherFinancingActivites 0 -49 000 57 000 0 7000.000 -630 000 159 000
netCashUsedProvidedByFinancingActivities 158 000 -12 000 48 000 -9000.000 122 000 87 000 151 000
effectOfForexChangesOnCash 0 4M 0 -4M 0 0 0
netChangeInCash -2M 499 000 -5M 4M -3M 1M -24M
cashAtEndOfPeriod 22M 24M 24M 29M 25M 27M 26M
cashAtBeginningOfPeriod 24M 24M 29M 25M 27M 26M 50M
operatingCashFlow -16M -9M -10M -9M -17M -12M -15M
capitalExpenditure -585 000 -418 000 -453 000 -215 000 -759 000 -811 000 -2M
freeCashFlow -16M -10M -10M -9M -17M -12M -17M
link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link

Earning call transcript

2024 q1
2024-05-03 ET (fiscal 2024 q1)
2023 q4
2024-03-01 ET (fiscal 2023 q4)
2023 q3
2023-11-03 ET (fiscal 2023 q3)
2023 q2
2023-08-04 ET (fiscal 2023 q2)
2023 q1
2023-05-05 ET (fiscal 2023 q1)
2022 q4
2023-03-03 ET (fiscal 2022 q4)
2022 q3
2022-11-13 ET (fiscal 2022 q3)
2022 q2
2022-08-13 ET (fiscal 2022 q2)
2022 q1
2022-05-14 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-05-03 11:00 ET
Rapid Micro Biosystems Reports First Quarter 2024 Financial Results
2024-04-18 20:30 ET
Rapid Micro Biosystems to Announce First Quarter 2024 Financial Results on May 3, 2024
2024-03-19 20:30 ET
Rapid Micro Biosystems to Exhibit at the 2024 PDA Annual Meeting from March 25 - 27, 2024
2024-03-12 20:50 ET
Rapid Micro Biosystems to Participate in the Virtual KeyBanc Life Sciences & MedTech Investor Forum
2024-03-06 23:40 ET
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2024-03-01 11:30 ET
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
2024-02-27 21:30 ET
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
2024-02-20 21:36 ET
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
2024-01-10 12:22 ET
Rapid Micro Biosystems Announces the Upcoming Availability of Rapid Sterility Application for the Growth Direct® System
2024-01-10 12:20 ET
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenue
2024-01-04 12:00 ET
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
2024-01-04 12:00 ET
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
2024-01-03 12:15 ET
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
2023-11-07 21:15 ET
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
2023-11-03 11:00 ET
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
2023-10-19 20:15 ET
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
2023-09-29 13:25 ET
Rapid Micro Biosystems to Exhibit at the 2023 PDA Pharmaceutical Microbiology Conference from October 2 – 4
2023-09-19 21:15 ET
Rapid Micro Biosystems to Participate in the Virtual Gilmartin Group Emerging Growth Company Showcase
2023-09-06 20:15 ET
Rapid Micro Biosystems to Participate in the Morgan Stanley 21st Annual Global HealthCare Conference
2023-08-04 11:00 ET
Rapid Micro Biosystems Reports Second Quarter 2023 Financial Results
2023-07-20 12:00 ET
Rapid Micro Biosystems to Announce Second Quarter 2023 Financial Results on August 4, 2023
2023-07-18 21:20 ET
Rapid Micro Biosystems Announces Appointment of Kirk Malloy, Ph.D. as Chair of its Board of Directors
2023-05-09 21:45 ET
Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2023-05-05 11:00 ET
Rapid Micro Biosystems Reports First Quarter 2023 Financial Results
2023-05-04 20:30 ET
Rapid Micro Biosystems Announces the Appointment of Michael Wysocki as Senior Vice President, Sales and Marketing
2023-04-13 20:05 ET
Rapid Micro Biosystems to Announce First Quarter 2023 Financial Results on May 5, 2023
2023-03-03 12:00 ET
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Full Year 2023 Guidance
2023-02-28 21:52 ET
Rapid Micro Biosystems to Participate in the Cowen 43rd Annual Health Care Conference
2023-02-16 21:05 ET
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2022 Financial Results on March 3, 2023
2023-01-11 14:00 ET
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Revenue
2023-01-05 13:00 ET
Rapid Micro Biosystems to Present at 41st Annual J.P. Morgan Healthcare Conference
2022-12-07 21:30 ET
Rapid Micro Biosystems® Announces Publication of a Multi-Author Case Study Supporting Fully Automated Colony Counting in Pharmaceutical Microbiology
2022-12-01 13:00 ET
Rapid Micro Biosystems Concludes Review of Strategic Alternatives
2022-11-10 12:00 ET
Rapid Micro Biosystems Reports Third Quarter 2022 Financial Results
2022-11-02 12:00 ET
Rapid Micro Biosystems to Announce Third Quarter 2022 Financial Results on November 10, 2022
2022-10-10 12:30 ET
Rapid Micro Biosystems Announces RMBNucleus™ Mold Alarm for the Growth Direct® System
2022-10-04 12:30 ET
Rapid Micro Biosystems to Exhibit at the 2022 PDA Pharmaceutical Microbiology Conference
2022-09-12 13:00 ET
Rapid Micro Biosystems CEO Rob Spignesi to Speak at the 2022 PDA/FDA Joint Regulatory Conference
2022-08-12 11:00 ET
Rapid Micro Biosystems Provides Business Update and Reports Second Quarter 2022 Financial Results
2022-08-12 11:00 ET
Rapid Micro Biosystems Announces Review of Strategic Alternatives to Maximize Shareholder Value
2022-08-09 12:00 ET
Rapid Micro Biosystems to Announce Second Quarter 2022 Financial Results on August 12, 2022
2022-06-30 18:33 ET
Rapid Micro Biosystems Confirms Receipt of Unsolicited, Non-Binding Proposal from Kennedy Lewis Investment Management
2022-06-30 12:30 ET
Kennedy Lewis Investment Management LLC Announces Offer to Acquire Rapid Micro Biosystems
2022-05-10 10:00 ET
Rapid Micro Biosystems Reports First Quarter 2022 Financial Results
2022-04-26 20:10 ET
Rapid Micro Biosystems to Announce First Quarter 2022 Financial Results on May 10, 2022
2022-03-04 11:00 ET
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2021 Financial Results and Reaffirms Full Year 2022 Guidance
2022-02-23 21:45 ET
Rapid Micro Biosystems to Participate at the Cowen 42nd Annual Health Care Conference
2022-02-17 21:10 ET
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2021 Financial Results on March 4, 2022
2022-01-20 21:30 ET
Rapid Micro Biosystems Appoints Michael Beaulieu as Vice President, Investor Relations and Corporate Communications
2022-01-09 23:00 ET
Rapid Micro Biosystems Announces Preliminary Unaudited Fourth Quarter and Full Year 2021 Revenue and Provides 2022 Revenue Outlook
2021-12-23 22:16 ET
Rapid Micro Biosystems Announces Appointment of Inese Lowenstein to Board of Directors
2021-11-11 23:15 ET
Rapid Micro Biosystems Reports Third Quarter 2021 Financial Results
2021-10-29 11:30 ET
Rapid Micro Biosystems to Present at Stifel 2021 Virtual Healthcare Conference
2021-10-19 11:30 ET
Rapid Micro to Announce Third Quarter 2021 Financial Results on November 11, 2021
2021-10-05 21:15 ET
Rapid Micro Biosystems Announces Appointment of Andy Keys as Chief Commercial Officer
2021-09-30 16:20 ET
Rapid Micro Biosystems to Exhibit at the 2021 PDA Pharmaceutical Microbiology Conference on October 4-6
2021-09-09 11:30 ET
Rapid Micro Biosystems Set to Join Russell 2000®, Russell 3000® and Russell Microcap® Indexes
2021-08-31 12:00 ET
Rapid Micro Biosystems to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
2021-08-26 20:05 ET
Rapid Micro Biosystems Reports Second Quarter 2021 Financial Results and Provides Business Update and Full Year 2021 Outlook
2021-08-12 20:30 ET
Rapid Micro Biosystems to Announce Second Quarter 2021 Financial Results on August 26, 2021
2021-08-04 20:28 ET
Rapid Micro Biosystems Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering
2021-08-04 20:28 ET
Rapid Micro Biosystems Announces Exercise and Closing of Over-Allotment Option in Initial Public Offering
2021-08-03 20:30 ET
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
2021-08-03 20:30 ET
Rapid Micro Biosystems Announces Appointment of Melinda Litherland to Board of Directors
2021-07-20 11:00 ET
Longitude Capital Raises Inaugural Opportunities Fund with $135 Million to Invest in Breakout Healthcare Companies
2021-07-15 01:30 ET
Rapid Micro Biosystems Announces Pricing of Initial Public Offering
2021-07-15 01:30 ET
Rapid Micro Biosystems Announces Pricing of Initial Public Offering

SEC forms

Show financial reports only

SEC form 10
2024-05-03 16:11 ET
Rapid Micro Biosystems, Inc. published news for 2024 q1
SEC form 8
2024-05-03 07:03 ET
Rapid Micro Biosystems, Inc. published news for 2024 q1
SEC form 8
2024-05-03 07:03 ET
Rapid Micro Biosystems, Inc. reported for 2024 q1
SEC form 10
2024-05-03 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2024 q1
SEC form 10
2024-03-01 16:38 ET
Rapid Micro Biosystems, Inc. published news for 2023 q4
SEC form 8
2024-03-01 06:33 ET
Rapid Micro Biosystems, Inc. published news for 2023 q4
SEC form 8
2024-03-01 06:33 ET
Rapid Micro Biosystems, Inc. reported for 2023 q4
SEC form 10
2024-03-01 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q4
SEC form 8
2024-01-10 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q4
SEC form 10
2023-11-03 16:16 ET
Rapid Micro Biosystems, Inc. published news for 2023 q3
SEC form 8
2023-11-03 07:03 ET
Rapid Micro Biosystems, Inc. reported for 2023 q3
SEC form 10
2023-11-03 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q3
SEC form 10
2023-08-04 16:32 ET
Rapid Micro Biosystems, Inc. published news for 2023 q2
SEC form 6
2023-08-04 07:05 ET
Rapid Micro Biosystems, Inc. reported for 2023 q2
SEC form 8
2023-08-04 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q2
SEC form 10
2023-08-04 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q2
SEC form 6
2023-07-18 18:46 ET
Rapid Micro Biosystems, Inc. published news for 2023 q2
SEC form 6
2023-07-18 17:25 ET
Rapid Micro Biosystems, Inc. published news for 2023 q2
SEC form 10
2023-05-09 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q1
SEC form 8
2023-05-05 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2023 q1
SEC form 6
2023-03-21 17:09 ET
Rapid Micro Biosystems, Inc. published news for 2022 q4
SEC form 10
2023-03-10 17:30 ET
Rapid Micro Biosystems, Inc. reported for 2022 q4
SEC form 10
2023-03-10 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q4
SEC form 6
2023-03-03 07:04 ET
Rapid Micro Biosystems, Inc. published news for 2022 q4
SEC form 8
2023-03-03 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q4
SEC form 6
2023-01-11 09:04 ET
Rapid Micro Biosystems, Inc. published news for 2022 q4
SEC form 8
2023-01-11 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2022 q4
SEC form 6
2022-12-01 08:04 ET
Rapid Micro Biosystems, Inc. published news for 2022 q3
SEC form 10
2022-11-10 16:44 ET
Rapid Micro Biosystems, Inc. reported for 2022 q3
SEC form 6
2022-11-10 07:27 ET
Rapid Micro Biosystems, Inc. published news for 2022 q3
SEC form 10
2022-11-10 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q3
SEC form 8
2022-11-10 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q3
SEC form 10
2022-08-12 09:21 ET
Rapid Micro Biosystems, Inc. reported for 2022 q2
SEC form 6
2022-08-12 07:30 ET
Rapid Micro Biosystems, Inc. published news for 2022 q2
SEC form 10
2022-08-12 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q2
SEC form 6
2022-06-06 19:45 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 6
2022-06-01 20:00 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 6
2022-05-26 20:00 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 6
2022-05-26 17:06 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 6
2022-05-19 17:33 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 6
2022-05-19 17:32 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 10
2022-05-10 17:25 ET
Rapid Micro Biosystems, Inc. reported for 2022 q1
SEC form 6
2022-05-10 07:59 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 10
2022-05-10 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q1
SEC form 8
2022-05-10 00:00 ET
Rapid Micro Biosystems, Inc. reported for 2022 q1
SEC form 6
2022-04-08 16:29 ET
Rapid Micro Biosystems, Inc. published news for 2022 q1
SEC form 6
2022-03-29 17:01 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 10
2022-03-24 17:27 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 10
2022-03-24 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 6
2022-03-04 06:12 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 8
2022-03-04 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 6
2022-01-10 06:35 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 8
2022-01-10 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2021 q4
SEC form 6
2021-12-23 17:17 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 6
2021-12-21 18:51 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 10
2021-11-15 09:12 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 10
2021-11-15 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 6
2021-11-12 09:18 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 8
2021-11-12 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 6
2021-10-05 17:52 ET
Rapid Micro Biosystems, Inc. published news for 2021 q3
SEC form 6
2021-09-23 16:45 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 10
2021-08-27 08:01 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 10
2021-08-27 00:00 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-08-26 16:08 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-20 21:32 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-20 17:57 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:34 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:34 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:33 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:33 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:32 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:32 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:32 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:31 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:31 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:31 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:30 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2
SEC form 6
2021-07-14 19:30 ET
Rapid Micro Biosystems, Inc. published news for 2021 q2